Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | benzathine benzylpenicillin | 25137901 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | benzathine benzylpenicillin | 25137901 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | benzathine benzylpenicillin | 25137901 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | benzathine benzylpenicillin | 25137901 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | benzathine benzylpenicillin | 25137901 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | cefuroxime | 68094 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | cefuroxime | 68094 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | cefuroxime | 68094 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | cefuroxime | 68094 | drug-path |
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | cefuroxime | 68094 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | finasteride | 57363 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | finasteride | 57363 | drug-path |
Insulin signaling pathway | R-HSA-74752 | map04910 | finasteride | 57363 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | finasteride | 57363 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | finasteride | 57363 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | finasteride | 57363 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | finasteride | 57363 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | finasteride | 57363 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | finasteride | 57363 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | finasteride | 57363 | drug-path |